Abstract
Aminopeptidase A (APA) is a membrane-bound zinc metalloprotease cleaving, in the brain, the N-terminal aspartyl residue of angiotensin II to generate angiotensin III, which exerts a tonic stimulatory effect on the control of blood pressure in hypertensive animals. Using a refined APA structure derived from the human APA crystal structure, we docked the specific and selective APA inhibitor, EC33 in the presence of Ca2+. We report the presence in the S1 subsite of Arg-887 (Arg-878 in mouse APA), the guanidinium moiety of which established an interaction with the electronegative sulfonate group of EC33. Mutagenic replacement of Arg-878 with an alanine or a lysine residue decreased the affinity of the recombinant enzymes for the acidic substrate, α-L-glutamyl-β-naphthylamide, with a slight decrease in substrate hydrolysis velocity either with or without Ca2+. In the absence of Ca2+, the mutations modified the substrate specificity of APA for the acidic substrate, the mutated enzymes hydrolyzing more efficiently basic and neutral substrates, although the addition of Ca2+ partially restored the acidic substrate specificity. The analysis of the 3D models of the Arg-878 mutated APAs revealed a change in the volume of the S1 subsite, which may impair the binding and/or the optimal positioning of the substrate in the active site as well as its hydrolysis. These findings demonstrate the key role of Arg-878 together with Ca2 + in APA substrate specificity for N-terminal acidic amino acid residues by ensuring the optimal positioning of acidic substrates during catalysis.
Highlights
Aminopeptidase A (APA; EC 3.4.11.7) is a 160 kDa homodimeric type II Zn2+ membranebound aminopeptidase [1, 2]
APA belongs to the monozinc aminopeptidase family, which requires Zn2+ for catalytic activity
Arg 878 drives aminopeptidase A substrate specificity acidic amino acids and this is due in part to the presence of Ca2+ in the S1 subsite of the APA active site [22, 35]
Summary
Aminopeptidase A (APA; EC 3.4.11.7) is a 160 kDa homodimeric type II Zn2+ membranebound aminopeptidase [1, 2]. APA cleaves the N-terminal glutamyl or aspartyl residue from peptide substrates such as angiotensin II (AngII) and cholecystokinin-8 and is activated by Ca2+. Arg 878 drives aminopeptidase A substrate specificity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.